US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential with Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a leader in the healthcare sector specializing in drug manufacturing for animals, presents an intriguing opportunity for investors looking to..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Revenue Growth and Promising Analyst Ratings Spark Investor Interest

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, has been making waves with its focus on developing cutting-edge oncology treatments. The company’s market capitalization..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating the Biotech Terrain with Precision

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, commands attention with a market capitalization of $2.73 billion. Specializing in the development and..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook Reveals 60% Potential Upside in Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant attention in the biotechnology sector with its promising pipeline aimed at rare neuroendocrine diseases. With a robust market..

ADMA Biologics Inc (ADMA) Stock Analysis: Could an 83% Potential Upside Be Within Reach?

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing the attention of investors with a significant potential upside. With a market..

BeOne Medicines Ltd. (ONC) Investor Outlook: Exploring a 35.71% Potential Upside in the Oncology Powerhouse

For investors seeking a strategic entry into the biotechnology sector, BeOne Medicines Ltd. (ONC) presents a compelling opportunity with its robust pipeline of oncology treatments and..

BrightSpring Health Services (BTSG) Stock Analysis: Revenue Growth and Analyst Confidence Signal Promising Potential

BrightSpring Health Services, Inc. (NYSE: BTSG) is making waves in the healthcare sector, specifically in health information services. With a current market capitalization of $9.3 billion,..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Growth Potential in the Healthcare Sector

Masimo Corporation (MASI), a notable player in the healthcare sector, specializes in medical devices that revolutionize patient monitoring and connectivity solutions. Headquartered in Irvine, California, the..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 29.97% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology firm, is catching the attention of investors with a promising potential upside of nearly 30%. As a leader..

Humana Inc. (HUM)

⚠️ No article content returned.

..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Significant 42% Upside Potential Beckons Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneering biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to addressing debilitating diseases through muscle..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: 59.38% Potential Upside Ignites Investor Interest

iRhythm Holdings, Inc. (NASDAQ: IRTC) stands at the forefront of the digital healthcare sector, focusing on the design and commercialization of cutting-edge medical devices for cardiac..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 9.10% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with its innovative offerings..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a Potential 16.52% Upside in Healthcare

Investors with an eye on the healthcare sector may want to take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a company that has..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating a 12.81% Potential Upside in Medical Devices

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, remains a key player in the medical devices industry. Founded in 1927 and headquartered..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 33.89% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. The company, with a market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring an 8.41% Potential Upside in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, has carved a niche within the medical devices industry. With a market capitalization of..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 15.59% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, primarily focusing on developing genetic medicines that address diseases with unmet medical needs. As..

Genmab A/S (GMAB) Stock Analysis: Unlocking a 40% Upside Potential with Biotech Innovation

Genmab A/S (NASDAQ: GMAB), an influential player in the biotechnology sector, commands attention with its promising portfolio of antibody-based products aimed at combating cancer and other..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds